Neurotransmitter-mediated open-field behavioral action of CGRP

Life Sci. 1999;64(9):733-40. doi: 10.1016/s0024-3205(99)00002-8.

Abstract

The effects of central administration of calcitonin gene-related peptide (CGRP) on open-field activity were examined in male rats. Three doses (250 ng, 500 ng and 1 microg) of CGRP given intracerebroventricularly (i.c.v.) were tested on the ambulatory, rearing and grooming activities of the animals. One microg of peptide significantly decreased the ambulatory activity and increased the rearing and grooming activities 30 min after the treatment. The animals were pretreated with different receptor antagonists in doses which by itself did not affect the behavioural paradigm. The decrease in ambulation induced by CGRP was antagonized by acetylcholine-, opioid-, 5HT-receptor and beta-adrenoceptor antagonists. CGRP induced increase in rearing activity was blocked by naloxone, phenoxybenzamine and propranolol. The CGRP-induced increase in grooming behavior was prevented by atropine, haloperidol, naloxone, methysergide and propranolol. The results suggest that different neurotransmitter systems are involved in the action of CGRP on open-field behavior in rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atropine / pharmacology
  • Behavior, Animal / drug effects*
  • Calcitonin Gene-Related Peptide / pharmacology*
  • Calcitonin Gene-Related Peptide Receptor Antagonists
  • Exploratory Behavior / drug effects
  • Exploratory Behavior / physiology
  • Grooming / drug effects
  • Grooming / physiology
  • Haloperidol / pharmacology
  • Injections, Intraventricular
  • Locomotion / drug effects
  • Locomotion / physiology
  • Male
  • Methysergide / pharmacology
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Naloxone / pharmacology
  • Phenoxybenzamine
  • Propranolol / pharmacology
  • Rats
  • Rats, Wistar

Substances

  • Calcitonin Gene-Related Peptide Receptor Antagonists
  • Phenoxybenzamine
  • Naloxone
  • Atropine
  • Propranolol
  • Haloperidol
  • Calcitonin Gene-Related Peptide
  • Methysergide